Clinical Trial Update: Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST) [Phase 4]

View source ↗

Summary

Phase 4 trial assessing safety and efficacy of aspirin in stroke patients with G6PD deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• G6pd Deficiency
• Stroke

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: G6PD Deficiency, Stroke | Phase 4 | Status: UNKNOWN